E-resources
-
Stepniewska, Kasia; Humphreys, Georgina S; Gonçalves, Bronner P; Craig, Elaine; Gosling, Roly; Guerin, Philippe J; Price, Ric N; Barnes, Karen I; Raman, Jaishree; Smit, Menno R; D’Alessandro, Umberto; Stone, Will J R; Bjorkman, Anders; Samuels, Aaron M; Arroyo-Arroyo, Maria I; Bastiaens, Guido J H; Brown, Joelle M; Dicko, Alassane; El-Sayed, Badria B; Elzaki, Salah-Eldin G; Eziefula, Alice C; Kariuki, Simon; Kwambai, Titus K; Maestre, Amanda E; Martensson, Andreas; Mosha, Dominic; Mwaiswelo, Richard O; Ngasala, Billy E; Okebe, Joseph; Roh, Michelle E; Sawa, Patrick; Tiono, Alfred B; Chen, Ingrid; Drakeley, Chris J; Bousema, Teun
The Journal of infectious diseases, 04/2022, Volume: 225, Issue: 7Journal Article
Abstract Background Since the World Health Organization recommended single low-dose (0.25 mg/kg) primaquine (PQ) in combination with artemisinin-based combination therapies (ACTs) in areas of low transmission or artemisinin-resistant Plasmodium falciparum, several single-site studies have been conducted to assess efficacy. Methods An individual patient meta-analysis to assess gametocytocidal and transmission-blocking efficacy of PQ in combination with different ACTs was conducted. Random effects logistic regression was used to quantify PQ effect on (1) gametocyte carriage in the first 2 weeks post treatment; and (2) the probability of infecting at least 1 mosquito or of a mosquito becoming infected. Results In 2574 participants from 14 studies, PQ reduced PCR-determined gametocyte carriage on days 7 and 14, most apparently in patients presenting with gametocytemia on day 0 (odds ratio OR, 0.22; 95% confidence interval CI, .17–.28 and OR, 0.12; 95% CI, .08–.16, respectively). Rate of decline in gametocyte carriage was faster when PQ was combined with artemether-lumefantrine (AL) compared to dihydroartemisinin-piperaquine (DP) (P = .010 for day 7). Addition of 0.25 mg/kg PQ was associated with near complete prevention of transmission to mosquitoes. Conclusions Transmission blocking is achieved with 0.25 mg/kg PQ. Gametocyte persistence and infectivity are lower when PQ is combined with AL compared to DP. An individual patient meta-analysis was performed on the gametocytocidal and transmission-blocking activities of single-dose primaquine. Gametocyte persistence and infectivity depended on the artemisinin-combination therapy that primaquine was administered with. Primaquine’s transmission-blocking effects were achieved at 0.25 mg/kg.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.